U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07063238) titled 'A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)' on July 03.
Brief Summary: Researchers are looking for new medicines to prevent Human Immunodeficiency Virus Type 1 (HIV-1) infection. HIV-1 is the most common type of HIV, which is a virus that attacks cells of the immune system. Medicines to prevent HIV-1 infection are called pre-exposure prophylaxis (PrEP). Some people may have trouble following a PrEP plan because it involves either taking medicine everyday by mouth or getting injections (shots) often.
MK-8527 is a study medicine designed to prevent HIV-1 infection. MK-8527 is different from standard (usua...